• Leveraging WP1066, a JAK2/STAT3 Inhibitor, in Regeneration &

  2026-08-06

  WP1066, a cell-permeable JAK2/STAT3 inhibitor from APExBIO, enables precision dissection and modulation of the JAK2/STAT3 axis in both cancer and regenerative models. This article provides actionable workflows, protocol parameters, and troubleshooting insights to maximize reproducibility and translational relevance.

• PARP1/FAK/COL5A1 Axis Drives EMT in Cholesterol-Resistant Ov

  2026-08-06

  This study uncovers how persistent high cholesterol promotes ovarian cancer progression by activating the PARP1/FAK/COL5A1 signaling pathway, leading to enhanced epithelial-mesenchymal transition (EMT). The work establishes cholesterol-resistant ovarian cancer cell models and provides mechanistic insights into tumor adaptation and potential therapeutic targets for drug-resistant disease.

• JSH-23: Precision NF-κB Inhibitor Workflows for Inflammation

  2026-08-05

  JSH-23 enables targeted, reproducible inhibition of NF-κB transcriptional activity, supporting high-confidence workflows in both cell and animal models. This guide synthesizes the latest experimental insights, protocol refinements, and troubleshooting strategies to accelerate inflammation research and clarify NF-κB pathway contributions.

• Quercetin Mitigates Cataract via Hippo Pathway Modulation in

  2026-08-05

  This study establishes quercetin’s ability to protect against cataract formation in a UVB-induced mouse model by suppressing the Hippo signaling pathway. The findings demonstrate a mechanistic link between Hippo pathway inactivation, improved oxidative stress profiles, and enhanced lens epithelial cell survival, suggesting new avenues for non-surgical cataract intervention.

• Flavopiridol (A3417): Reliable CDK Inhibition for Cell Cycle

  2026-08-04

  This article delivers a scenario-driven, evidence-based exploration of Flavopiridol (SKU A3417) for cell viability, proliferation, and cytotoxicity assays. It addresses practical experimental challenges, provides data-backed guidance for protocol optimization, and compares vendor reliability, ensuring biomedical researchers achieve reproducible results with this pan-CDK inhibitor.

• AZD-3463: Structural Precision and Pathway Selectivity in AL

  2026-08-04

  Explore how AZD3463, a leading ALK/IGF1R inhibitor, sets new standards in neuroblastoma research through structural selectivity and advanced pathway modulation. This article offers a uniquely detailed assay-design perspective, integrating structural insights and practical protocol guidance.

• Oleanolic Acid Triggers Liver Injury via FXR Pathway Disrupt

  2026-08-03

  This study reveals that oleanolic acid (OA) induces hepatic injury by impairing hepatocyte tight junctions and dysregulating FXR-mediated bile acid efflux transporters, specifically BSEP and MRP2. The findings clarify the mechanistic link between OA exposure, tight junction integrity, and bile acid transporter function, providing new avenues for investigating FXR’s protective roles in liver physiology.

• Leucomycin (Kitasamycin): Advanced Applications in Translati

  2026-08-03

  Leucomycin (kitasamycin) empowers researchers with a robust, broad-spectrum macrolide for dissecting bacterial protein synthesis and resistance mechanisms. This article details state-of-the-art workflows, optimization strategies, and troubleshooting guidance to maximize data quality in translational inhibition and antibacterial drug discovery using APExBIO’s high-purity Leucomycin.

• UK-5099 (PF-1005023): A Precision Tool for Mitochondrial Met

  2026-08-02

  Explore how UK-5099 (PF-1005023) uniquely enables high-resolution studies of mitochondrial metabolism and immune modulation. This article details advanced protocol strategies, scientific insights, and practical assay guidance for researchers using this potent pyruvate carrier inhibitor.

• CHK1 Inhibition in Breast Cancer: Impacts of Hormone Recepto

  2026-08-01

  This article examines how the reference study reveals the variable role of CHK1 inhibition in breast cancer, depending on estrogen and progesterone receptor status. The findings highlight the importance of molecular subtyping for optimizing targeted therapies, with implications for future research on epigenetic modulators and apoptosis pathways.

• 3D Osteocyte Networks Respond to Pulsatile Fluid Flow via Co

  2026-07-31

  This study introduces a microfluidic model enabling precise investigation of mechanotransduction in 3D osteocyte networks under pulsatile unidirectional fluid flow. The findings clarify how dynamic mechanical cues propagate calcium signals via connexin 43 junctions, with implications for bone biology and gap junction research.

• IDO1 Inhibition Drives Tumor STAT3 Activation: Implications

  2026-07-31

  Yu et al. reveal that pharmacological inhibition of IDO1, while intended to restore anti-tumor immunity, can paradoxically activate the tumor-intrinsic JAK2/STAT3 pathway via increased IL-6 secretion, fostering tumor cell survival. These findings underscore the critical importance of co-targeting the JAK2/STAT3 axis in IDO1 inhibitor-based cancer therapies and provide a mechanistic rationale for combining IDO1 inhibitors with JAK2/STAT3 pathway inhibitors such as AZD1480.

• Phosbind Biotin: Dinuclear Metal Complex for Phosphorylation

  2026-07-30

  Phos binding reagent (Phosbind) Biotin leverages dinuclear metal complex phosphate binding to deliver robust, sequence-independent detection of phosphorylated proteins in Western blot workflows. Its unique chemistry enables sensitive protein phosphorylation analysis even when phospho-specific antibodies fall short, empowering advanced signal transduction research and troubleshooting.

• Diuron in Mechanistic Toxicology: Pathways, Protocols, and E

  2026-07-30

  Explore the advanced toxicological mechanisms of Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) with new insights into renal injury pathways and practical research protocols. This article uniquely bridges molecular findings with environmental and laboratory implications.

• Short-Scale BIR and DNA Damage Amplification in Mouse Oocyte

  2026-07-29

  This study reveals that double-strand breaks (DSBs) in fully grown mouse oocytes induce a unique form of short-scale break-induced replication (ssBIR), amplifying DNA damage via Rad51 and DNA polymerase-dependent mechanisms. These findings clarify oocyte genome stability and introduce new assay strategies for investigating DNA repair using chain-terminating analogs such as ddATP.

455 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page